12-lipoxygenase promotes tumor progress by TGF-β1-mediated epithelial to mesenchymal transition and predicts poor prognosis in esophageal squamous cell carcinoma

References

• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386. doi:10.1002/ijc.2921025220842
   PubMed Web of Science ®Google Scholar
• Lin Y, Totsuka Y, He Y, et al. Epidemiology of esophageal cancer in Japan and China. J Epidemiol. 2013;23(4):233–242. doi:10.2188/jea.je2012016223629646
   PubMed Web of Science ®Google Scholar
• Lagergren J, Lagergren P. Oesophageal cancer. BMJ. 2010;341:c6280. doi:10.1136/bmj.c628021112905
   PubMedGoogle Scholar
• Ding XZ, Hennig R, Adrian TE. Lipoxygenase and cyclooxygenase metabolism: new insights in treatment and chemoprevention of pancreatic cancer. Mol Cancer. 2003;2:10. doi:10.1186/1476-4598-2-1012575899
   PubMedGoogle Scholar
• Liu Q, Tan W, Che J, et al. 12-HETE facilitates cell survival by activating the integrin-linked kinase/NF-kappaB pathway in ovarian cancer. Cancer Manag Res. 2018;10:5825–5838. doi:10.2147/CMAR.S18033430510451
   PubMed Web of Science ®Google Scholar
• Pidgeon GP, Kandouz M, Meram A, Honn KV. Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells. Cancer Res. 2002;62(9):2721–2727.11980674
   PubMed Web of Science ®Google Scholar
• Yoshimura R, Inoue K, Kawahito Y, et al. Expression of 12-lipoxygenase in human renal cell carcinoma and growth prevention by its inhibitor. Int J Mol Med. 2004;13(1):41–46.14654968
   PubMed Web of Science ®Google Scholar
• Yoshimura R, Matsuyama M, Tsuchida K, Kawahito Y, Sano H, Nakatani T. Expression of lipoxygenase in human bladder carcinoma and growth inhibition by its inhibitors. J Urol. 2003;170(5):1994–1999. doi:10.1097/01.ju.0000080296.54262.c814532840
   PubMed Web of Science ®Google Scholar
• Zhi H, Zhang J, Hu G, et al. The deregulation of arachidonic acid metabolism-related genes in human esophageal squamous cell carcinoma. Int J Cancer. 2003;106(3):327–333. doi:10.1002/ijc.1122512845669
   PubMed Web of Science ®Google Scholar
• Liu X, Yun F, Shi L, Li ZH, Luo NR, Jia YF. Roles of signaling pathways in the epithelial-mesenchymal transition in cancer. Asian Pac J Cancer Prev. 2015;16(15):6201–6206. doi:10.7314/apjcp.2015.16.15.620126434817
   PubMedGoogle Scholar
• Gonzalez DM, Medici D. Signaling mechanisms of the epithelial-mesenchymal transition. Sci Signal. 2014;7(344):re8. doi:10.1126/scisignal.200518925249658
   PubMed Web of Science ®Google Scholar
• Moustakas A, Heldin CH. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci. 2007;98(10):1512–1520. doi:10.1111/j.1349-7006.2007.00550.x17645776
   PubMed Web of Science ®Google Scholar
• Wong BC, Wang WP, Cho CH, et al. 12-lipoxygenase inhibition induced apoptosis in human gastric cancer cells. Carcinogenesis. 2001;22(9):1349–1354. doi:10.1093/carcin/22.9.134911532854
   PubMed Web of Science ®Google Scholar
• Xu XM, Yuan GJ, Deng JJ, et al. Inhibition of 12-lipoxygenase reduces proliferation and induces apoptosis of hepatocellular carcinoma cells in vitro and in vivo. Hepatobiliary Pancreatic Dis Int. 2012;11(2):193–202. doi:10.1016/S1499-3872(12)60147-7
   PubMed Web of Science ®Google Scholar
• Agarwal S, Achari C, Praveen D, Roy KR, Reddy GV, Reddanna P. Inhibition of 12-LOX and COX-2 reduces the proliferation of human epidermoid carcinoma cells (A431) by modulating the ERK and PI3K-Akt signalling pathways. Exp Dermatol. 2009;18(11):939–946. doi:10.1111/j.1600-0625.2009.00874.x19558494
   PubMed Web of Science ®Google Scholar
• Chen FL, Wang XZ, Li JY, Yu JP, Huang CY, Chen ZX. 12-lipoxygenase induces apoptosis of human gastric cancer AGS cells via the ERK1/2 signal pathway. Dig Dis Sci. 2008;53(1):181–187. doi:10.1007/s10620-007-9841-117522976
   PubMed Web of Science ®Google Scholar
• Leung HW, Yang WH, Lai MY, Lin CJ, Lee HZ. Inhibition of 12-lipoxygenase during baicalein-induced human lung nonsmall carcinoma H460 cell apoptosis. Food Chem Toxicol. 2007;45(3):403–411. doi:10.1016/j.fct.2006.08.02117050058
   PubMed Web of Science ®Google Scholar
• Camp RL, Rimm EB, Rimm DL. Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma. Cancer. 1999;86(11):2259–2265. doi:10.1002/(sici)1097-0142(19991201)86:11<2259::aid-cncr13>3.0.co;2-210590366
   PubMed Web of Science ®Google Scholar
• Pang L, Li Q, Wei C, et al. TGF-β1/Smad signaling pathway regulates epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: in vitro and clinical analyses of cell lines and nomadic Kazakh patients from northwest Xinjiang, China. PLoS One. 2014;9(12):e112300. doi:10.1371/journal.pone.011230025464508
   PubMed Web of Science ®Google Scholar
• Guo Y, Zhang W, Giroux C, et al. Identification of the orphan G protein-coupled receptor GPR31 as a receptor for 12-(S)-hydroxyeicosatetraenoic acid. J Biol Chem. 2011;286(39):33832–33840. doi:10.1074/jbc.M110.21656421712392
   PubMed Web of Science ®Google Scholar
• Dilly AK, Ekambaram P, Guo Y, et al. Platelet-type 12-lipoxygenase induces MMP9 expression and cellular invasion via activation of PI3K/Akt/NF-kappaB. Int J Cancer. 2013;133(8):1784–1791. doi:10.1002/ijc.2816523526143
   PubMed Web of Science ®Google Scholar
• Zhong C, Zhuang M, Wang X, et al. 12-lipoxygenase promotes invasion and metastasis of human gastric cancer cells via epithelial-mesenchymal transition. Oncol Lett. 2018;16(2):1455–1462. doi:10.3892/ol.2018.880830008824
   PubMed Web of Science ®Google Scholar
• Kopf S, Viola K, Atanasov AG, et al. In vitro characterisation of the anti-intravasative properties of the marine product heteronemin. Arch Toxicol. 2013;87(10):1851–1861. doi:10.1007/s00204-013-1045-123543012
   PubMed Web of Science ®Google Scholar